We employed an ACSL4-specific inhibitor and silenced ACSL4 gene expression to determine the impact on ferroptosis activation and consequently on renal injury and renal fibrosis, both in vivo and in vitro. The gene discussed is ACSL4; the disease is renal fibrosis.